1. Home
  2. CSTE vs RFL Comparison

CSTE vs RFL Comparison

Compare CSTE & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

N/A

Current Price

$0.74

Market Cap

27.7M

Sector

Industrials

ML Signal

N/A

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

N/A

Current Price

$1.48

Market Cap

61.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CSTE
RFL
Founded
1987
2017
Country
Israel
United States
Employees
N/A
N/A
Industry
Building Materials
Real Estate
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
27.7M
61.1M
IPO Year
2012
2017

Fundamental Metrics

Financial Performance
Metric
CSTE
RFL
Price
$0.74
$1.48
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
319.6K
91.0K
Earning Date
01-01-0001
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.28
EPS
N/A
N/A
Revenue
N/A
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.96
52 Week Low
$0.71
$1.12
52 Week High
$3.26
$3.19

Technical Indicators

Market Signals
Indicator
CSTE
RFL
Relative Strength Index (RSI) 19.98 65.63
Support Level N/A $1.41
Resistance Level $2.00 $1.63
Average True Range (ATR) 0.16 0.10
MACD -0.08 0.02
Stochastic Oscillator 3.60 71.25

Price Performance

Historical Comparison
CSTE
RFL

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: